Condition: Preeclampsia · Pregnancy Complications · Diabetes Mellitus in Pregnancy · Sponsor: Charite University, Berlin, Germany
This study will investigate the interplay of different immune cells and placental cells as well as their potential for the development of pregnancy complications. In particular, the translation of the uteroplacental syndrome into a maternal syndrome, considered in the multifactorial pregnancy disorder preeclampsia, will be investigated. Immune cell subtypes are causally involved in the formation and translation of preeclampsia by inducing an endothelial dysfunction which leads to cardiovascular damage.
This description comes directly from the study's public registry record.
Florian Herse, PhD · +49 30 450 540 434 · florian.herse@charite.de
Always discuss trial participation with your own doctor first.
| Experimental and Clinical Research Center (ECRC) | Berlin, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03313024